BBT BEACON FINANCIAL
Financials · Russell 2000
Next earnings: Wed 27 Jan 2027 · estimated
What 8 analyst firms say about BEACON FINANCIAL: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8033
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8046
Recent analyst activity · last 90 days
Our tracked history has 8 reports on BBT from 6 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Keefe Bruyette raised its target from $36.00 (set 30 Jan 2026) to $38.00 on 23 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Hovde Group | David Bishop | Hold | 31 Jul 2026 | 33.00 USD |
| Keefe Bruyette & Woods | David J Konrad | Buy | 23 Oct 2026 | 38.00 USD |
| Piper Sandler | Justin Crowley | Buy | 27 Oct 2026 | 35.00 USD |
| Raymond James | Steve Moss | Hold | 22 Sep 2026 | — |
| RBC Capital Markets | Jon G Arfstrom | Hold | 3 Aug 2026 | Conflicting reports · excluded |
| RBC Capital Markets | Karl Shepard | Hold | 23 Oct 2026 | 33.00 USD |
| Seaport Research Partners | Laurie H Hunsicker | Buy | 21 Sep 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 3 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:51 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.